These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 3106483)

  • 1. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis.
    Balloul JM; Grzych JM; Pierce RJ; Capron A
    J Immunol; 1987 May; 138(10):3448-53. PubMed ID: 3106483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against experimental Schistosoma mansoni schistosomiasis achieved by immunization with schistosomula released products antigens (SRP-A): role of IgE antibodies.
    Damonneville M; Auriault C; Verwaerde C; Delanoye A; Pierce R; Capron A
    Clin Exp Immunol; 1986 Aug; 65(2):244-52. PubMed ID: 3098476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional properties of a rat monoclonal IgE antibody specific for Schistosoma mansoni.
    Verwaerde C; Joseph M; Capron M; Pierce RJ; Damonneville M; Velge F; Auriault C; Capron A
    J Immunol; 1987 Jun; 138(12):4441-6. PubMed ID: 3108390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. 1. Partial protection of Fischer rat after active immunization.
    Wolowczuk I; Auriault C; Bossus M; Boulanger D; Gras-Masse H; Mazingue C; Pierce RJ; Grezel D; Reid GD; Tartar A
    J Immunol; 1991 Mar; 146(6):1987-95. PubMed ID: 1900878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1 antigen.
    Wolowczuk I; Auriault C; Gras-Masse H; Vendeville C; Balloul JM; Tartar A; Capron A
    J Immunol; 1989 Feb; 142(4):1342-50. PubMed ID: 2492579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides.
    Auriault C; Gras-Masse H; Wolowczuk I; Pierce RJ; Balloul JM; Neyrinck JL; Drobecq H; Tartar A; Capron A
    J Immunol; 1988 Sep; 141(5):1687-94. PubMed ID: 2457624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin.
    Flanigan TP; King CH; Lett RR; Nanduri J; Mahmoud AA
    J Clin Invest; 1989 Mar; 83(3):1010-4. PubMed ID: 2493482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice.
    Jwo J; LoVerde PT
    J Parasitol; 1989 Apr; 75(2):252-60. PubMed ID: 2466975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of a protective antigen for adjuvant-free immunization against Schistosoma mansoni.
    King CH; Lett RR; Nanduri J; el Ibiary S; Peters PA; Olds GR; Mahmoud AA
    J Immunol; 1987 Dec; 139(12):4218-24. PubMed ID: 3121733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
    Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
    Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective monoclonal antibodies from mice vaccinated or chronically infected with Schistosoma mansoni that recognize the same antigens.
    Gregoire RJ; Shi MH; Rekosh DM; Loverde PT
    J Immunol; 1987 Dec; 139(11):3792-801. PubMed ID: 2445819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses to the fucosylated LacdiNAc glycan antigen in Schistosoma mansoni-infected mice and expression of the glycan among schistosomes.
    Nyame AK; Leppänen AM; Bogitsh BJ; Cummings RD
    Exp Parasitol; 2000 Dec; 96(4):202-12. PubMed ID: 11162373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effector function of rat IgG2a monoclonal anti-S. mansoni antibodies.
    Grzych JM; Capron M; Bazin H; Capron A
    J Immunol; 1982 Dec; 129(6):2739-43. PubMed ID: 7142705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defined antigens secreted by the larvae of schistosomes protect against schistosomiasis: induction of cytotoxic antibodies in the rat and the monkey.
    Auriault C; Damonneville M; Joseph M; Capron M; Verwaerde C; Billaut P; Capron A
    Eur J Immunol; 1985 Dec; 15(12):1168-72. PubMed ID: 3936720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of a T cell line specific for antiidiotypic antibodies to a Schistosoma mansoni protective epitope. II. Induction of protective immunity in experimental rat schistosomiasis.
    Velge-Roussel F; Auriault C; Damonneville M; Capron A
    J Immunol; 1991 Dec; 147(11):3967-72. PubMed ID: 1719096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.